•  COS-LEP Phase 3

    What is the objective?

    Phase 3 will involve exploring outcomes of interest with healthcare providers and end-users directly affected by leptospirosis, to identify outcomes important to these groups

    How will we do this?

    Through focused interviews with participants, we will explore key topics regarding the participant's experience of treatment of leptospirosis as well as potential outcomes of interest.

    What will this add?

    Outcomes lists generated from Phase 1 & 2 will be supplemented by perspectives of the general public and healthcare providers. Future trial target population groups can be identified and acceptability of therapeutic interventions can be explored.

  • Resources and forms for general public and patients

    Section image

    Participant Information Form

    Information regarding the COS-LEP Phase 3 study for patients and general public. Provided in .docx format.

    Section image

    Consent Form

    Consent form for the COS-LEP Phase 3 study for patients and general public. Provided in .doxc format.

    Resources and forms for healthcare professional

    Section image

    Participant Information Form (Healthcare professional)

    Information regarding the COS-LEP Phase 3 study for healthcare professionals. Provided in .docx format.

    Section image

    Consent Form (Healthcare professionals)

    Consent form for the COS-LEP Phase 3 study for healthcare professionals. Provided in .doxc format.

    Section image

    Phase 3 updates

    Updated 4/8/2025

    Enrollment completed at all sites. Data analysis ongoing.

Cookie Use
We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
Learn More